• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT B-HCG CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT B-HCG CARTRIDGE Back to Search Results
Catalog Number 05P58-25
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Codes Memory Loss/Impairment (1958); Nausea (1970); Dysphasia (2195); Numbness (2415); Hallucination (4428)
Date of Event 08/11/2023
Type of Reportable Event Malfunction
Event or Problem Description
On 19-jan-2024, abbott point of care (apoc) was contacted by a customer regarding i-stat b-hcg cartridges that yielded a positive result on a 27 year old female patient with dysphasia, slurred speech, nausea, memory loss, numbness, confusion, hallucinations.There was no additional patient information at the time of this report.Return product is not available for investigation.Method; date; collected; tested & result(iu/ml).I-stat, (b)(6) 2023, 07:22pm, 07:34pm & 63.6.Roche, (b)(6) 2023, ni, ni & <5.0.There are no injuries associated with this event.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The investigation is underway.I-stat positive cut-off values: b-hcg < 5.0 iu/l negative.5.0 < ss-hcg < 25.0 iu/l indeterminate.B-hcg >25.0 iu/l positive.Intended use: the i-stat® total beta-human chorionic gonadotropin (b-hcg) test is an in vitro diagnostic test for the quantitative and qualitative determination of b-hcg in venous whole blood or plasma samples using the i-stat 1 analyzer systems.The test is intended to be used as an aid in the early detection of pregnancy and is for prescription use only.
 
Additional Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling was evaluated during the investigation as pertaining to the event.
 
Additional Manufacturer Narrative
Apoc incident: # (b)(4).The investigation was completed on 25-apr-2024.A review of the device history record confirmed the cartridge lot met finished goods release criteria.Retained cartridge testing met the acceptance criteria outlined in appendix 1 of q04.01.003 rev.An (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified for total b-hcg cartridge lot m23176.
 
Event or Problem Description
Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT B-HCG CARTRIDGE
Common Device Name
B-HCG CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
Manufacturer (Section G)
ABBOTT POINT OF CARE CANADA LTD.
185 corkstown road
K2H 8 V4
CA   K2H 8V4
Manufacturer Contact
linda maczuszenko
185 corkstown road
princeton, NJ K2H 8-V4
CA   K2H 8V4
6136123525
MDR Report Key18702677
Report Number2245578-2024-00038
Device Sequence Number6194560
Product Code DHA
UDI-Device Identifier10054749001009
UDI-Public10054749001009
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K133002
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/09/2023
Device Catalogue Number05P58-25
Device Lot NumberM23176
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/19/2024
Supplement Date Received by Manufacturer04/25/2024
Initial Report FDA Received Date02/14/2024
Supplement Report FDA Received Date04/29/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/25/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age27 YR
Patient SexFemale
-
-